Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Ritz

Showing results (51-60 of 315) with videos related to

Pageof 32
Sort By:
The Journal of Investigative Dermatology|February 14, 2002
Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: basis for therapy of cutaneous T cell lymphomaMohamed H Zaki, Maria Wysocka, Suzanne E Everetts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cellsCatherine J Wu, Melinda Biernacki, Jeffery L Kutok, et al.
Cancer Research|May 17, 2003
Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusionEnrica Orsini, Roberto Bellucci, Edwin P Alyea, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell TransplantationMark Leick, Rachel M Gittelman, Erik Yusko, et al.
Cancer|February 22, 2017
Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinomaJulian Huang, Mark Fogg, Lori J Wirth, et al.
Blood|November 15, 2008
Protein disulfide isomerases are antibody targets during immune-mediated tumor destructionCatia Fonseca, Robert Soiffer, Vincent Ho, et al.
Journal of Pediatric Surgery|January 18, 2011
Preclinical regulatory validation of an engineered diaphragmatic tendon made with amniotic mesenchymal stem cellsChristopher G Turner, Justin D Klein, Shaun A Steigman, et al.
Cytotherapy|February 3, 2021
Comparative analysis of cell therapy infusion workflows at clinical sitesAdam Joules, Julianne Connors, Rachel Johnson, et al.
The Journal of Experimental Medicine|April 21, 2004
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantationEmmanuel Zorn, David B Miklos, Blair H Floyd, et al.
British Journal of Haematology|June 29, 2005
FLT3 inhibition in t(4;11)+ adult acute lymphoid leukaemiaGiovanni F Torelli, Anna Guarini, Alessandra Porzia, et al.
Pageof 32

Showing results (51-60 of 315) with videos related to

Sort By:
Pageof 32
The Journal of Investigative Dermatology|February 14, 2002
Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: basis for therapy of cutaneous T cell lymphomaMohamed H Zaki, Maria Wysocka, Suzanne E Everetts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cellsCatherine J Wu, Melinda Biernacki, Jeffery L Kutok, et al.
Cancer Research|May 17, 2003
Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusionEnrica Orsini, Roberto Bellucci, Edwin P Alyea, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell TransplantationMark Leick, Rachel M Gittelman, Erik Yusko, et al.
Cancer|February 22, 2017
Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinomaJulian Huang, Mark Fogg, Lori J Wirth, et al.
Blood|November 15, 2008
Protein disulfide isomerases are antibody targets during immune-mediated tumor destructionCatia Fonseca, Robert Soiffer, Vincent Ho, et al.
Journal of Pediatric Surgery|January 18, 2011
Preclinical regulatory validation of an engineered diaphragmatic tendon made with amniotic mesenchymal stem cellsChristopher G Turner, Justin D Klein, Shaun A Steigman, et al.
Cytotherapy|February 3, 2021
Comparative analysis of cell therapy infusion workflows at clinical sitesAdam Joules, Julianne Connors, Rachel Johnson, et al.
The Journal of Experimental Medicine|April 21, 2004
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantationEmmanuel Zorn, David B Miklos, Blair H Floyd, et al.
British Journal of Haematology|June 29, 2005
FLT3 inhibition in t(4;11)+ adult acute lymphoid leukaemiaGiovanni F Torelli, Anna Guarini, Alessandra Porzia, et al.
Pageof 32